| Company Name: |
Xi'an Confluore Biological Technology Co., Ltd.
|
| Tel: |
+86-156-80926068 +86-15680926068 |
| Email: |
1924344760@qq.com |
| Products Intro: |
Product Name:Thalidomide-O-PEG1-azide
CAS:2758432-02-7
Purity:98% HPLC Package:10MG;25MG;50MG;100MG;1G;5G Remarks:For customers outside China,please use the website:www.confluore.com
|
| Company Name: |
Nanjing Bestfluorodrug Pharmaceutical Technology CO.,LTD
|
| Tel: |
025-86755008 17751752005 |
| Email: |
hszhang@bestfluorodrug.com |
| Products Intro: |
Product Name:4-(2-(2-azidoethoxy)ethoxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
CAS:2758432-02-7
Purity:95%+ Package:1g;5g;10g,25g
|
| Company Name: |
Nanjing Bestfluorodrug Pharmaceutical Technology CO.,LTD
|
| Tel: |
025-86755008 17751752005 |
| Email: |
hszhang@bestfluorodrug.com |
| Products Intro: |
Product Name:4-(2-(2-azidoethoxy)ethoxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
CAS:2758432-02-7
Purity:95%+ Package:1g;5g;10g;25g
|
Thalidomide-O-PEG1-azide manufacturers
- Thalidomide-O-PEG1-azide
-
- $0.00 / 100mg
-
2024-04-02
- CAS:2758432-02-7
- Min. Order: 100mg
- Purity: >98.00%
- Supply Ability: 100mg
|
| | Thalidomide-O-PEG1-azide Basic information |
| Product Name: | Thalidomide-O-PEG1-azide | | Synonyms: | Thalidomide-O-PEG1-azide;4-(2-(2-azidoethoxy)ethoxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione;1H-Isoindole-1,3(2H)-dione, 4-[2-(2-azidoethoxy)ethoxy]-2-(2,6-dioxo-3-piperidinyl)- | | CAS: | 2758432-02-7 | | MF: | C17H17N5O6 | | MW: | 387.35 | | EINECS: | | | Product Categories: | | | Mol File: | 2758432-02-7.mol |  |
| | Thalidomide-O-PEG1-azide Chemical Properties |
| | Thalidomide-O-PEG1-azide Usage And Synthesis |
| Biological Activity | Thalidomide 4'-ether-PEG1-azide is a functionalized cereblon ligand for PROTAC? research and development; incorporates an E3 ligase ligand plus a PEG1 linker with azide terminal ready for conjugation to a target protein ligand. | | storage | Store at -20°C |
| | Thalidomide-O-PEG1-azide Preparation Products And Raw materials |
|